Abstract

Invasive mucinous adenocarcinoma (IMA) of the lung frequently presents with diffuse pneumonic-type features or multifocal lesions, which are regarded as a pattern of intrapulmonary metastases. However, the genomics of multifocal IMAs have not been well studied. We performed whole exome sequencing on samples taken from 2 to 5 regions in seven patients with synchronous multifocal IMAs of the lung (24 regions total). Early initiating driver events, such as KRAS, NKX2-1, TP53, or ARID1A mutations, are clonal mutations and were present in all multifocal IMAs in each patient. The tumor mutational burden of multifocal IMAs was low (mean: 1.13/mega base), but further analyses suggested intra-tumor heterogeneity. The mutational signature analysis found that IMAs were predominantly associated with endogenous mutational process (signature 1), APOBEC activity (signatures 2 and 13), and defective DNA mismatch repair (signature 6), but not related to smoking signature. IMAs synchronously located in the bilateral lower lobes of two patients with background usual interstitial pneumonia had different mutation types, suggesting that they were double primaries. In conclusion, genomic evidence found in this study indicated the clonal intrapulmonary spread of diffuse pneumonic-type or multifocal IMAs, although they can occur in multicentric origins in the background of usual interstitial pneumonia. IMAs exhibited a heterogeneous genomic landscape despite the low somatic mutation burden. Further studies are warranted to determine the clinical significance of the genomic characteristics of IMAs in expanded cohorts.

Highlights

  • Lung cancer is the leading cause of cancer-related deaths worldwide

  • Immunohistochemistry showed the loss of TTF-1/NKX2-1 protein expression, the lineage-specific protein, which is frequently used to distinguish between lung and other organ adenocarcinomas, in more than 80% of Invasive mucinous adenocarcinoma (IMA) [6, 7]

  • Eight patients with synchronous multifocal IMAs resected by surgery were enrolled in this study and designated as P01–P08, respectively

Read more

Summary

Introduction

The most common subtype of lung cancer is adenocarcinoma [1]. Invasive mucinous adenocarcinoma (IMA) accounts for approximately 5% of all lung adenocarcinoma cases [2]. Recurrence in the lungs is frequently observed, extrathoracic or nodal metastasis can occur [5]. Immunohistochemistry showed the loss of TTF-1/NKX2-1 protein expression, the lineage-specific protein, which is frequently used to distinguish between lung and other organ adenocarcinomas, in more than 80% of IMAs [6, 7]. KRAS mutations are the most common type of oncogenic driver mutations [5, 7,8,9]. In addition to KRAS mutations, BRAF and ERBB2 mutations, and gene rearrangements of NRG1 have been observed [5, 9,10,11,12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call